期刊文献+
共找到277篇文章
< 1 2 14 >
每页显示 20 50 100
Disulfiram thermosensitive in-situ gel based on solid dispersion for cataract 被引量:3
1
作者 Chunjuan Zhang Tonghua Xu +3 位作者 Donglei Zhang Wei He Siling Wang Tongying Jiang 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2018年第6期527-535,共9页
To improve the corneal permeability and water-solubility of disulfiram(DSF), which is an ocular drug for cataract, P188 was selected as a matrix to prepare solid dispersion of DSF(DSF SD) by hot melt method. The DSF S... To improve the corneal permeability and water-solubility of disulfiram(DSF), which is an ocular drug for cataract, P188 was selected as a matrix to prepare solid dispersion of DSF(DSF SD) by hot melt method. The DSF SD was characterized by DSC, XRD, and IR, and the results suggested that DSF was amorphous in DSF SD. The DSF SD was added to borate buffer solution(BBS) contained 20% poloxamer P407 and 1.2% poloxamer P188 to form in-situ gel. In vitro and in vivo experiments revealed that DSF SD combined with in-situ gel(DSF SD/in-situ gel) increased the residence time and the amount of DSF penetrated through the corneal. The pharmacodynamics studies exhibited DSF SD/in-situ gel delayed the development of selenium-induced cataract at some content. These results investigated that DSF SD/in-situ gel as a drug delivery system can improve DSF ocular permeability. 展开更多
关键词 DISULFIRAM Solid dispersion in-situ gel PERMEABILITY Anti-cataract
下载PDF
Preparation and evaluation of ophthalmic thermosensitive in situ gels of penciclovir 被引量:7
2
作者 李桂玲 李眉 《Journal of Chinese Pharmaceutical Sciences》 CAS 2007年第2期90-95,共6页
Aim To develop pluronic F127 (PF127) based formulations of penciclovir (PCV) aimed at enhancing its ocular bioavailability. Methods Thermosensitive in situ gels of penciclovir were prepared through combination of ... Aim To develop pluronic F127 (PF127) based formulations of penciclovir (PCV) aimed at enhancing its ocular bioavailability. Methods Thermosensitive in situ gels of penciclovir were prepared through combination of HPMC K4M or carbopol 934P and pluronic F127. Optimized formulations were examined through measuring gelation temperature, rheology speciality, drug release behavior, pharmacokinetics and ocular irritation. Results The gelation temperature was reduced by adding HPMC K4M or carbopol 934P, and the viscosity was enhanced slightly. Either HPMC K4M or carbopol 934P delayed the release of PCV from in situ gel. PCV was released by non-Fickian diffusion. The study of ocular irritation for different PCV formulations did not show any irritation or damage for the cornea. PCV bioavailability from combination of carbopol 934P and pluronic F127 gels was higher than that obtained from any other gels. Conclusion Pluronic F127 formulations of PCV can be used as liquid for administration by instilling into the eye. Facilitated by the appropriate eye temperature, the formulations were transformed to gel phase. On the basis of in vitro and in vivo results, PCV formulations containing HPMC K4M or carbopol 934P and low concentration of pluronic F127 (12%) showed potential for use as a drug delivery system with improved ocular bioavailability. 展开更多
关键词 PENCICLOVIR thermosensitive in situ forming gel PLURONIC Rbeology Drug release Ocular irritation PHARMACOKINETICS
下载PDF
The preparation of Thermosensitive in Situ Gel of Iodine
3
作者 刘宁 李明春 马守栋 《科技风》 2015年第9期2-2,9,共2页
objective:To Investigate the preparation,dissolution and release in vitro of thermosensitive in situ gel of iodine.Methods:Using orthogonal test method for screening the best prescription;Using the formula of gel accu... objective:To Investigate the preparation,dissolution and release in vitro of thermosensitive in situ gel of iodine.Methods:Using orthogonal test method for screening the best prescription;Using the formula of gel accumulative dissolution percentage=(W1-Wt)/(W1-W0)to calculate the dissolution rate of Q by membrane-free;Calculating the accumulative release rate by the standard curve.As time increases,the dissolution rate and the release rate of the gel increased significantly.Conclusion:Thermosensitive in situ gel of iodine has good sustained release effect. 展开更多
关键词 医学 临床 诊断 医院
下载PDF
Molecular Reactivity and Interface Stability Modification in In-Situ Gel Electrolyte for High Performance Quasi-Solid-State Lithium Metal Batteries 被引量:1
4
作者 Qiyu Wang Xiangqun Xu +4 位作者 Bo Hong Maohui Bai Jie Li Zhian Zhang Yanqing Lai 《Energy & Environmental Materials》 SCIE EI CAS CSCD 2023年第3期8-19,共12页
Quasi-solid-state lithium metal battery is a promising candidate for next generation high energy density and high safety power supply.Despite intensive efforts on electrolytes,uncontrolled interfacial reactions on lit... Quasi-solid-state lithium metal battery is a promising candidate for next generation high energy density and high safety power supply.Despite intensive efforts on electrolytes,uncontrolled interfacial reactions on lithium with electrolyte and patchy interfacial contacts still hinder its practical process.Herein,we bring in rationally designed F contained groups into polymer skeleton via in-situ gelation for the first time to establish quasi-solid-state battery.This method achieves a capacity retention of 90%after 1000 cycles at 0.5C with LiFePO_(4)cathodes.The interface constructed by polymer skeleton and reaction with–CF_(3)lead to the predicted solid electrolyte interface species with high stability.Furthermore,we optimize molecular reactivity and interface stability with regulating F contained end groups in the polymer.Comparisons on different structures reveal that high performance solid stable lithium metal batteries rely on chemical modification as well as stable polymer skeleton,which is more critical to construct robust and steady SEI with uniform lithium deposition.New approach with functional groups regulation proposes a more stable cycling process with a capacity retention of 94.2%at 0.5C and 87.6%at 1C after 1000 cycles with LiFePO_(4) cathodes,providing new insights for the practical development of quasi-solid-state lithium metal battery. 展开更多
关键词 F contained end groups in-situ gel electrolyte interface stability molecular reactivity quasi-solid-state lithium metal battery
下载PDF
Preparation Process of Plumbagin Nanomicelle In-situ Gel
5
作者 Xuemei LU Wanyu ZUO +4 位作者 Yun LI Weiyu WANG Ruyin DONG Luyang LU Jizhong ZHANG 《Medicinal Plant》 2023年第6期35-38,42,共5页
[Objectives]To prepare plumbagin nanomicelle(PLB-N)in-situ gel,and optimize the formulation and process.[Methods]PLB-N was prepared by self-assembly method,and the optimal formulation of PLB-N in-situ gel was determin... [Objectives]To prepare plumbagin nanomicelle(PLB-N)in-situ gel,and optimize the formulation and process.[Methods]PLB-N was prepared by self-assembly method,and the optimal formulation of PLB-N in-situ gel was determined by orthogonal experiment design and single factor method.[Results]The optimal preparation process for PLB-N was a drug to lipid ratio of 1:3,a Tween 80 content of 5%,an ethanol content of 7.5%of the hydration medium,a magnetic stirring speed of 2200 rpm,a stirring time of 30 min,and an ultrasound time of 10 min.The optimal formulation of PLB-N in-situ gel was 22%of poloxamer 407,6%of poloxamer 188,and 1:1 of PLB-N to water.The encapsulation efficiency of PLB-N prepared with the optimal formula was(95.8%±0.4%),and the average particle size was(75.19±1.14)nm,and the Zeta potential was(-20.73±1.19)mv.[Conclusions]PLB-N in-situ gel had stable and reliable preparation process,uniform content,and broad application prospects. 展开更多
关键词 PLUMBAGIN Nanomicelle in-situ gel Preparation process
下载PDF
Research progress of in-situ gelling ophthalmic drug delivery system 被引量:11
6
作者 Yumei Wu Yuanyuan Liu +7 位作者 Xinyue Li Dereje Kebebe Bing Zhang Jing Ren Jun Lu Jiawei Li Shouying Du Zhidong Liu 《Asian Journal of Pharmaceutical Sciences》 SCIE 2019年第1期1-15,I0001,共16页
Blindness and vision impairment are the most devastating global health problems resulting in a substantial economic and social burden.Delivery of drug to particular parts of the anterior or posterior segment has been ... Blindness and vision impairment are the most devastating global health problems resulting in a substantial economic and social burden.Delivery of drug to particular parts of the anterior or posterior segment has been a major challenge due to various protective barriers and elimination mechanisms associated with the unique anatomical and physiological nature of the ocular system.Drug administration to the eye by conventional delivery systems results in poor ocular bioavailability(<5%).The designing of a novel approach for a safe,simple,and effective ocular drug delivery is a major concern and requires innovative strategies to combat the problem.Over the past decades,several novel approaches involving different strategies have been developed to improve the ocular delivery system.Among these,the ophthalmic in-situ gel has attained a great attention over the past few years.This review discussed and summarized the recent and the promising research progress of in-situ gelling in ocular drug delivery system. 展开更多
关键词 in-situ gel OCULAR Drug delivery BIOAVAILABILITY Polymer CORNEAL RETENTION
下载PDF
A comprehensive review of in-situ polymer gel simulation for conformance control 被引量:2
7
作者 Baojun Bai Jianqiao Leng Mingzhen Wei 《Petroleum Science》 SCIE CAS CSCD 2022年第1期189-202,共14页
Gel treatment has been widely applied in mature oilfields to improve sweep efficiency and control water production.Correct numerical simulation is of major importance to the optimization design and prediction of a suc... Gel treatment has been widely applied in mature oilfields to improve sweep efficiency and control water production.Correct numerical simulation is of major importance to the optimization design and prediction of a successful gel treatment.However,there exist many problems in current simulation studies in published literature.This paper first presents a comprehensive review on the major factors that have been considered at different gelation stages during gel treatment,the models used in the commercial/inhouse simulators,and current numerical simulation studies on both laboratory and field scales.Then we classify the current in-situ gel numerical simulation problems as 1,deficient model problem that has published numerical model but has not been applied in simulator and application studies;2,missing model problem that does not have published quantitative model;and 3,inaccurate application problem that does not consider the major factors of gel performance,based on the reasons from some questionable results of current simulation studies.Finally,we point out the major research efforts that should be made in the future to better simulate in-situ gel treatment process.The review indicates that numerous simulation studies using commercial software packages intend to predigest the gel treatment,many of which,however,ignore important mechanisms and mislead the operation of gel treatment.In fact,a full assessment of simulating in-situ gels cannot be achieved unless the quantitative models can be qualified in terms of transport and plugging mechanisms based on the experimental results. 展开更多
关键词 in-situ gel MECHANISM Simulation model Application studies
下载PDF
载阿霉素纳米粒温敏凝胶复合体系的体内缓释性能和抗肿瘤作用及瘤内滞留性能评价
8
作者 杜华康 陆苑 +4 位作者 金阳 陈玉颖 王永林 李勇军 刘文 《贵州医科大学学报》 CAS 2024年第3期361-367,374,共8页
目的探讨载阿霉素(DOX)纳米粒温敏凝胶(DOX-NPs-Gel)复合体系的体内缓释性能、抗肿瘤作用及瘤内滞留性能。方法18只SD雄性大鼠随机均分为DOX组、DOX-碘油组(4 g/L DOX溶液1 mL与碘油1 mL混匀现配,5 mL/kg)及DOX-NPs-Gel组(5 mg/kg DOX+2... 目的探讨载阿霉素(DOX)纳米粒温敏凝胶(DOX-NPs-Gel)复合体系的体内缓释性能、抗肿瘤作用及瘤内滞留性能。方法18只SD雄性大鼠随机均分为DOX组、DOX-碘油组(4 g/L DOX溶液1 mL与碘油1 mL混匀现配,5 mL/kg)及DOX-NPs-Gel组(5 mg/kg DOX+2 g/L DOX),腹腔注射,分别于给药后不同时间点经眼底静脉丛穿刺取血,采用超高效液相色谱-串联质谱(UPLC-MS/MS)技术检测血浆中DOX的浓度,利用WinNonLin 8.1软件拟合主要药代参数[半衰期(t 1/2)、峰浓度(C max)、曲线下面积(AUC)、清除率(CL)、平均驻留时间(MRT)];培养、收集小鼠肝癌细胞株H22细胞制成悬液,单次接种于90只雄性ICR小鼠右腋皮下构建荷瘤模型,分2部分进行实验,第一部分取荷瘤小鼠36只均分为生理盐水组(注射用生理盐水,5 mL/kg)、空白NPs-Gel组(100 mg空白NPs冻干粉分散于1 mL空白Gel,5 mL/kg)、碘油组(碘油,5 mL/kg)、DOX组(2 g/L DOX,5 mL/kg)、DOX-碘油组(4 g/L DOX溶液1 mL与碘油1 mL混匀现配,5 mL/kg)及DOX-NPs-Gel组(2 g/L DOX,5 mL/kg),瘤内注射、给药1次,观测10 d,给药后每2天称体质量1次并计算各组小鼠的体质量变化百分比,称重后同时测量各组小鼠瘤体宽度、长度并计算肿瘤体积(V),观测结束时脱颈处死、剥离肿瘤组织,称取各组小鼠瘤体质量并计算抑瘤率,然后制作切片采用苏木精-伊红(HE)染色观察组织学特征;第二部分取荷瘤小鼠54只均分为DOX组、DOX-碘油组及DOX-NPs-Gel组,给药剂量和途径同前,给药后12、24、48、72、96及120 h时取各组3只小鼠脱颈处死,剥离肿瘤组织,采用UPLC-MS/MS检测瘤体组织中各时间点的DOX瘤内滞留率。结果体内缓释性能研究结果显示,相比于其余组,DOX-NPs-Gel组大鼠t 1/2延长、CL降低(P<0.05);抗肿瘤作用考察结果显示,与其它治疗组相比,DOX-NPs-Gel组小鼠肿瘤组织生长最慢,瘤重降低(P<0.05),抑瘤率最高(76.55%),HE染色显示肿瘤组织出现大范围凋亡和坏死情况;瘤内滞留性能考察结果显示,DOX-NPs-Gel组小鼠第5天时滞留率为(44.14±3.84)%,其余组第4天时滞留率已降至0%。结论与DOX和DOX-碘油相比,DOX-NPs-Gel在动物体内具有更强的缓释性能、抗肿瘤作用及瘤内滞留性能。 展开更多
关键词 纳米粒 温敏凝胶 药代动力学 抗肿瘤作用 缓释作用 肝动脉化疗栓塞术
下载PDF
载阿霉素纳米粒温敏凝胶的制备及评价
9
作者 杜华康 陆苑 +4 位作者 金阳 陈玉颖 王永林 李勇军 刘文 《贵州医科大学学报》 CAS 2024年第1期71-79,共9页
目的 对制备出可用于肝动脉化疗栓塞(TACE)的载阿霉素纳米粒温敏凝胶(DOX-NPs-Gel)复合体系的相关特性进行评价。方法 以乳酸-羟基乙酸共聚物(PLGA)为载体,采用复乳法制备载阿霉素纳米粒(DOX-NPs),考察其外观、粒径、PDI和Zeta电位,经... 目的 对制备出可用于肝动脉化疗栓塞(TACE)的载阿霉素纳米粒温敏凝胶(DOX-NPs-Gel)复合体系的相关特性进行评价。方法 以乳酸-羟基乙酸共聚物(PLGA)为载体,采用复乳法制备载阿霉素纳米粒(DOX-NPs),考察其外观、粒径、PDI和Zeta电位,经冷冻干燥得DOX-NPs冻干粉,将其分散于壳聚糖(CS)/β-甘油磷酸(β-GP)温敏凝胶(Gel),制得DOX-NPs-Gel;采用倒瓶法考察Gel、DOX-Gel、空白-NPs-Gel及DOX-NPs-Gel在37℃下的胶凝化时间及胶凝温度;扫描电镜观察微观结构;通过兔耳中动脉栓塞实验考察了空白-NPs-Gel的栓塞性能;通过在皮下注射空白-NPs-Gel于不同时间脱颈死小鼠,剥离出空白-NPs-Gel,测量其大小及质量,评价其吸收特性;采用动态膜透析法考察DOX、DOX-NPs、DOX-Gel的体外释放;采用无膜溶出法考察DOX-NPs-Gel的体外释放。结果 制备出的DOX-NPs形态规则,粒径为(186.68±5.99)nm,多分散系数(PDI)为(0.17±0.01),Zeta电位为(-23.33±1.54)mV,包封率和载药量分别为(77.10±4.46)%和(2.64±0.19)%;DOX-NPs-Gel 37℃下胶凝化时间为(165±15)s,胶凝化温度为(34.67±0.47)℃,冻干后其微观结构为整齐紧密的多孔结构;该复合体系可顺利通过微导管注射,可栓塞兔耳中动脉,且在皮下可被缓慢吸收;体外释放结果显示,第7天时DOX-NPs-Gel中DOX和DOX-NPs的释放率分别为(6.15±0.19)%和(47.25±5.11)%。结论 本研究制备的DOX-NPs-Gel在体温下可快速胶凝、可栓塞血管和皮下吸收,能够缓慢释放DOX-NPs。 展开更多
关键词 肝动脉化疗栓塞 温敏凝胶 纳米粒 阿霉素 缓释制剂 体外释放
下载PDF
聚吡咯基温敏凝胶的制备及性能研究
10
作者 邹锐 陈晓亮 +1 位作者 张丽莎 余诺 《东华大学学报(自然科学版)》 CAS 北大核心 2024年第2期70-75,共6页
为了明确纳米温敏凝胶在光控药物释放和光热治疗等方面的应用价值,通过无皂乳液聚合法,使用单体N-异丙基丙烯酰胺(N-isopropylacrylamide,NIPAM)与壳聚糖(chitosan,CS)合成了体积相转变温度为38.5℃,并具有明显的温敏性的PNIPAM/CS复合... 为了明确纳米温敏凝胶在光控药物释放和光热治疗等方面的应用价值,通过无皂乳液聚合法,使用单体N-异丙基丙烯酰胺(N-isopropylacrylamide,NIPAM)与壳聚糖(chitosan,CS)合成了体积相转变温度为38.5℃,并具有明显的温敏性的PNIPAM/CS复合温敏凝胶;利用原位吸附法在PNIPAM/CS凝胶颗粒表面生长聚吡咯(polypyrrole,PPy)光响应层,获得结构为球形,尺寸分布为100~200 nm的PNIPAM/CS@PPy纳米凝胶。当温度从20℃增加到42℃时,凝胶颗粒的水合粒径从250 nm下降到140 nm,表现出温度变化驱动的体积收缩性能。研究结果表明:纳米凝胶颗粒具有较强的吸收近红外光功能;在808 nm激光照射下,纳米凝胶具有强光热转换性能,其光热升温随着浓度的增加而增强;PNIPAM/CS@PPy在温控药物释放和光热治疗等方面具有潜在的应用价值。 展开更多
关键词 温敏凝胶 纳米凝胶 聚吡咯 光热效应
下载PDF
Box-Behnken效应面法优化盐酸达克罗宁温敏凝胶的处方工艺
11
作者 李娇 潘娇娇 +3 位作者 徐丽芝 陈卫东 王淑君 杨瑞 《中南药学》 CAS 2024年第4期936-942,共7页
目的制备盐酸达克罗宁温敏凝胶(DH-Gel),并对其进行稳定性、体外释放和刺激性考察。方法以胶凝温度为评价指标,采用单因素试验和Box-Behnken效应面法优化DH-Gel处方;以性状、pH、胶凝温度、药物含量变化为评价指标,考察DH-Gel在不同条... 目的制备盐酸达克罗宁温敏凝胶(DH-Gel),并对其进行稳定性、体外释放和刺激性考察。方法以胶凝温度为评价指标,采用单因素试验和Box-Behnken效应面法优化DH-Gel处方;以性状、pH、胶凝温度、药物含量变化为评价指标,考察DH-Gel在不同条件下的稳定性;以扩散池法考察凝胶体外释药行为;采用家兔眼刺激性试验考察DH-Gel的刺激性。结果最佳处方是盐酸达克罗宁用量为1%,泊洛沙姆407用量为19.39%,泊洛沙姆188用量为1.96%,羟丙基甲基纤维素用量为0.30%,苯甲酸钠用量为0.01%;在高温和低温条件下稳定性良好;凝胶的体外释药遵从Ritger-Peppas动力学方程,为Fick扩散;DH-Gel组刺激性程度小于盐酸达克罗宁溶液组。结论制备的DH-Gel具有理想的胶凝温度,能使药物更持久有效地黏附在给药部位,具有给药方便等优点。 展开更多
关键词 盐酸达克罗宁 温敏凝胶 BOX-BEHNKEN效应面法 体外释放
下载PDF
直肠用美沙拉嗪温敏凝胶的制备及质量评价
12
作者 潘娇娇 李娇 +4 位作者 丁杨 刘彤 杨瑞 桂双英 王淑君 《中南药学》 CAS 2024年第5期1164-1169,共6页
目的 制备一种具有缓释和保留性能,用于直肠给药的美沙拉嗪温敏凝胶(MZ-Gel)。方法 以胶凝温度为评价指标,采用星点设计-响应面法对泊洛沙姆407和泊洛沙姆188的用量进行优化。以Franz扩散池法进一步考察体外释药行为,得到最佳处方并对... 目的 制备一种具有缓释和保留性能,用于直肠给药的美沙拉嗪温敏凝胶(MZ-Gel)。方法 以胶凝温度为评价指标,采用星点设计-响应面法对泊洛沙姆407和泊洛沙姆188的用量进行优化。以Franz扩散池法进一步考察体外释药行为,得到最佳处方并对其进行质量评价。结果 MZ-Gel优化处方为P407 22.56%,P188 3.34%,胶凝温度为(32.8±0.3)℃;MZ-Gel的体外释药符合一级动力学特征,具有缓释效果;胶凝时间平均值为38.3 s,pH平均值为4.07,膨胀系数平均值为4.81%,持水率平均值为99.78%;红外表征表明,美沙拉嗪的加入并没有破坏温敏凝胶结构。结论 此方法制备工艺简单,性质稳定且具有良好的体外释药特征。 展开更多
关键词 美沙拉嗪 温敏凝胶 星点设计-响应面法 Franz扩散池法 体外释药
下载PDF
白藜芦醇温敏凝胶的制备HepG-2人肝癌细胞的抑制作用
13
作者 高国铸 李磊 +3 位作者 范郁琳 汪海峰 梁梦秋 鞠婉婷 《当代化工》 CAS 2024年第5期1128-1133,共6页
以泊洛沙姆407(P407)、泊洛沙姆188(P188)为凝胶基质制备白藜芦醇温敏水凝胶,通过BoxBehnken Design(BBD)法优化处方后对其进行药剂学性质及质量评价,通过MTT法检测其对人肝癌HepG-2细胞的抑制活性。结果表明:确定的最优处方为P407质量... 以泊洛沙姆407(P407)、泊洛沙姆188(P188)为凝胶基质制备白藜芦醇温敏水凝胶,通过BoxBehnken Design(BBD)法优化处方后对其进行药剂学性质及质量评价,通过MTT法检测其对人肝癌HepG-2细胞的抑制活性。结果表明:确定的最优处方为P407质量分数为21.22%、P188质量分数为4.87%、P407与P188体积比为3∶1、白藜芦醇质量为2.5 mg;电镜结果显示其具有均匀致密的孔道,胶凝温度为36.4℃,胶凝时间为230 s,pH为7.12,黏度为1 784.6 mPa·s;溶蚀时间达6 h,溶蚀度为95.5%,药物释放可达到90%以上,凝胶系统稳定性良好,可稳定释放药物;MTT法检测发现能够有效抑制肿瘤细胞增长并有浓度依赖特性。制备的白藜芦醇温敏水凝胶具有良好的温敏效果,能够在局部形成药物储库,期待能为未来的临床应用及成果转化奠定基础。 展开更多
关键词 肿瘤 药物 温敏凝胶 聚合物
下载PDF
双黄补温敏凝胶的制备及体外释放考察
14
作者 安中原 冯白茹 +2 位作者 申茹 张新忠 余巧 《中医药导报》 2024年第3期75-79,共5页
目的:制备双黄补温敏凝胶,并考察其体外释放行为。方法:以提取时间、料液比、提取次数为影响因素,黄芩苷和盐酸小檗碱含量的综合评分为评价指标,采用正交试验优化提取工艺。以温敏凝胶基质用量为影响因素,胶凝温度为考察指标,优化处方... 目的:制备双黄补温敏凝胶,并考察其体外释放行为。方法:以提取时间、料液比、提取次数为影响因素,黄芩苷和盐酸小檗碱含量的综合评分为评价指标,采用正交试验优化提取工艺。以温敏凝胶基质用量为影响因素,胶凝温度为考察指标,优化处方工艺。最后通过透析袋法考察其体外释药行为。结果:最佳提取工艺为60%乙醇作为溶剂,提取时间0.5 h,料液比1∶20(m/V),提取3次;双黄补温敏凝胶最佳处方是17.0%的泊洛沙姆407(P407),1.0%的泊洛沙姆188(P188),0.7%的提取物,胶凝温度为34.3℃;黄芩苷的体外释放符合Higuchi方程,盐酸小檗碱的释放符合一级动力学方程。结论:双黄补温敏凝胶制备工艺稳定可行,为双黄补的开发提供了新剂型。 展开更多
关键词 双黄补 温敏凝胶 正交试验 制备 体外释放 高效液相色谱法
下载PDF
星点设计-效应面法优选连芩清热温敏凝胶制备工艺
15
作者 宋征 郑翠翠 +4 位作者 高新富 李梦飞 孙邵伟 吴丹丹 于振燕 《中国医药科学》 2023年第15期62-65,共4页
目的 优化连芩清热温敏凝胶剂的制备工艺。方法 以泊洛沙姆407用量、泊洛沙姆188用量、连芩清热洗剂原液用量为考察变量,以胶凝温度为考察指标,采用星点设计-效应面法确定优选制备工艺条件,并进行预测分析。结果 连芩清热温敏凝胶剂的... 目的 优化连芩清热温敏凝胶剂的制备工艺。方法 以泊洛沙姆407用量、泊洛沙姆188用量、连芩清热洗剂原液用量为考察变量,以胶凝温度为考察指标,采用星点设计-效应面法确定优选制备工艺条件,并进行预测分析。结果 连芩清热温敏凝胶剂的最优制备为:泊洛沙姆407用量17%,泊洛沙姆188用量3%,连芩清热洗剂原液用量比例为46%,连芩清热温敏凝胶的凝胶温度为30.4℃,凝胶时间为(14.8±2.1)s,凝胶长度(0.5±0.1)cm。结论 连芩清热温敏凝胶剂制备工艺简便,稳定性好,凝胶时间和凝胶长度合理。 展开更多
关键词 星点设计 效应面法 黄芩苷 温敏凝胶 含量测定
下载PDF
PNIPAM温敏凝胶对水泥材料抗硫酸盐侵蚀性能的影响
16
作者 王振军 史文涛 +2 位作者 张婷 李梦 王泽辉 《硅酸盐通报》 CAS 北大核心 2023年第2期429-438,共10页
利用自制聚N-异丙基丙烯酰胺(PNIPAM)温敏凝胶制备水泥材料,并开展硫酸盐溶液侵蚀试验,测量试件质量与强度变化;同时采用SEM、MIP和水化热测试等手段,研究PNIPAM凝胶对水泥材料抗硫酸盐侵蚀性能的影响机理。结果表明,PNIPAM凝胶相变会释... 利用自制聚N-异丙基丙烯酰胺(PNIPAM)温敏凝胶制备水泥材料,并开展硫酸盐溶液侵蚀试验,测量试件质量与强度变化;同时采用SEM、MIP和水化热测试等手段,研究PNIPAM凝胶对水泥材料抗硫酸盐侵蚀性能的影响机理。结果表明,PNIPAM凝胶相变会释水,促进水泥材料的水化,改善内部孔结构,提高水泥材料力学性能;质量分数为1.0%的PNIPAM凝胶可降低水泥材料受硫酸盐侵蚀的质量损失和强度损失;PNIIPAM凝胶具有相变特性,可以抵消部分膨胀型侵蚀产物对水泥材料内部造成的破坏,提高水泥材料的抗硫酸盐侵蚀性能。 展开更多
关键词 水泥材料 温敏凝胶 硫酸盐侵蚀 孔结构 干湿循环 水化热
下载PDF
酮咯酸氨丁三醇鼻用温敏凝胶的制备及体外释放研究 被引量:2
17
作者 种思茹 彭汐涯 +3 位作者 王欣茹 王淑君 叶田田 杨瑞 《中南药学》 CAS 2023年第4期857-863,共7页
目的优化酮咯酸氨丁三醇鼻用温敏凝胶(ketorolac tromethamine thermosensitive nasal gel,KT-Gel)处方,并对其体外释药机制进行研究。方法采用Box-Behnken效应面法优化KT-Gel处方;以无膜溶出法考察KT-Gel的体外溶蚀行为;以扩散池法考察... 目的优化酮咯酸氨丁三醇鼻用温敏凝胶(ketorolac tromethamine thermosensitive nasal gel,KT-Gel)处方,并对其体外释药机制进行研究。方法采用Box-Behnken效应面法优化KT-Gel处方;以无膜溶出法考察KT-Gel的体外溶蚀行为;以扩散池法考察KT-Gel的体外释药行为。结果KT-Gel最佳处方为泊洛沙姆40722.59%,泊洛沙姆1882.44%,羟丙基甲基纤维素0.31%,胶凝温度为(34.2±0.3)℃;凝胶的溶蚀符合一级动力学方程特征,体外释药遵从Ritger-Peppas动力学方程,为扩散与骨架溶蚀协同作用。结论采用Box-Behnken效应面法优化KT-Gel处方,所建模型预测性良好。KT-Gel释放受扩散和骨架溶蚀控制,可维持药物持续、稳定的释放。 展开更多
关键词 酮咯酸氨丁三醇 鼻用温敏凝胶 BOX-BEHNKEN效应面法 体外溶蚀 体外释药
下载PDF
耐温热敏聚合物冻胶的制备及性能评价 被引量:2
18
作者 胡煜 岳明 +3 位作者 郑伟 陈立峰 邓俊辉 刘靓 《石油化工》 CAS CSCD 北大核心 2023年第5期700-707,共8页
以丙烯酰胺/丙烯酰吗啉/N-乙烯基吡咯烷酮共聚物(AAN)为成胶剂、对苯二酚和乌洛托品为交联剂、硫脲为除氧剂、纳米SiO_(2)为高温稳定剂制备了冻胶,研究了聚合物、交联剂、除氧剂和高温稳定剂用量对冻胶成胶性能和热稳定性的影响。实验... 以丙烯酰胺/丙烯酰吗啉/N-乙烯基吡咯烷酮共聚物(AAN)为成胶剂、对苯二酚和乌洛托品为交联剂、硫脲为除氧剂、纳米SiO_(2)为高温稳定剂制备了冻胶,研究了聚合物、交联剂、除氧剂和高温稳定剂用量对冻胶成胶性能和热稳定性的影响。实验结果表明,聚合物链上伯酰胺基的水解是冻胶在高温下热稳定性差的主要原因,加入纳米SiO_(2)可有效抑制水解从而提高冻胶的强度和热稳定性。优化的冻胶组成为1.0%(w)热敏聚合物AAN、0.4%(w)对苯二酚、0.4%(w)乌洛托品、0.2%(w)硫脲、2.0%(w)纳米SiO2,该冻胶在165℃下的成胶时间为3 h,成胶后弹性模量为93.2 Pa,可在90 d内保持冻胶强度级别为H,脱水率小于5%;该冻胶对高渗通道有良好的封堵能力,封堵率在99.5%以上。 展开更多
关键词 冻胶 热敏聚合物 纳米SIO2 高温 缝洞型油藏
下载PDF
帕瑞昔布钠鼻用温敏凝胶的制备及其体外性质研究 被引量:1
19
作者 黄晶 谷福根 吴春芝 《中南药学》 2023年第8期2046-2052,共7页
目的 制备帕瑞昔布钠鼻用温敏凝胶(PS-TNG)并对其体外性质进行评价。方法 以胶凝温度为主要观察指标,采用星点设计-效应面法对PS-TNG处方进行优化,然后以离体羊鼻黏膜为模型,采用Franz透皮扩散池法筛选PS最佳促渗剂,最后制备PS-TNG并对... 目的 制备帕瑞昔布钠鼻用温敏凝胶(PS-TNG)并对其体外性质进行评价。方法 以胶凝温度为主要观察指标,采用星点设计-效应面法对PS-TNG处方进行优化,然后以离体羊鼻黏膜为模型,采用Franz透皮扩散池法筛选PS最佳促渗剂,最后制备PS-TNG并对其体外性质进行研究。分别测定该制剂的胶凝温度、胶凝时间、pH值、体外溶蚀率、药物释放率以及药物释放度,并考察温度和转速对制剂黏度的影响以及制剂的膨胀系数和持水能力。结果 PS-TNG理想处方组成为:5.0%PS、20.88%F127、3.28%F68、0.28%HPMC、5.0%HP-β-CD、0.05%尼泊金乙酯及适量水。测得PS-TNG的胶凝温度为32.2℃,胶凝时间为48.2 s,pH值为7.4;PS-TNG体外累积溶蚀与药物累积释放量间具有良好的线性关系(r=0.9997);制剂释放度试验表明,PS-TNG具明显缓释特征。此外,发现温度和搅拌对制剂的黏度均有明显影响,该制剂的持水能力强且膨胀系数小。结论 PS-TNG处方组成合理,制备工艺简单,其胶凝温度、胶凝时间、p H值、膨胀系数和持水能力适宜,药物缓释作用明显,预计有良好的临床应用前景。 展开更多
关键词 帕瑞昔布钠 鼻用温敏凝胶 星点设计-效应面法 吸收促渗剂 体外性质
下载PDF
SiO_(2) nanofiber composite gel polymer electrolyte by in-situ polymerization for stable Li metal batteries 被引量:2
20
作者 Zhichuan Shen Jiawei Zhong +5 位作者 Jiahong Chen Wenhao Xie Kun Yang Yuhan Lin Jinbiao Chen Zhicong Shi 《Chinese Chemical Letters》 SCIE CAS CSCD 2023年第3期536-540,共5页
Gel polymer electrolytes(GPEs) are promising alternatives to liquid electrolytes applied in high-energydensity batteries.Here superior SiO_(2) nanofiber composite gel polymer electrolytes(SNCGPEs) are developed via in... Gel polymer electrolytes(GPEs) are promising alternatives to liquid electrolytes applied in high-energydensity batteries.Here superior SiO_(2) nanofiber composite gel polymer electrolytes(SNCGPEs) are developed via in-situ ionic ring-opening polymerization of 1,3-dioxolane(DOL) monomers in SiO_(2) nanofiber membrane(PDOL-SiO_(2)) for lithium metal batteries.The oxygen atoms of PDOL together with Si-O of SiO_(2) construct a more efficient channel for Li^(+) migration.Consequently,the lithium ion transference number(t_(Li^(+)) and ionic conductivity(σ) at 30℃ of PDOL-SiO_(2) are 0.80 and 1.68×10^(-4)S/cm separately.PDOL-SiO_(2) manifests the electrochemical decomposition potentials of 4.90 V.At 0.5 mA/cm^(2),Li|PDOL-SiO_(2) |Li cell shows a steady cycling performance for nearly 1400 h.LFP|PDOL-SiO_(2) |Li battery can steadily cycle at 0.5 C with a capacity retention rate of 89% after 200 cycles.While cycling at 2 C,the capacity retention rate can maintain at 78% after 300 cycles.This contribution provides a innovative strategy for accelerating Li^(+)transportation via designing PDOL molecular chains throughout the SiO_(2) nanofiber framework,which is crucial for high-energy-density LMBs. 展开更多
关键词 SiO_(2)nanofiber in-situ polymerization Composite gel polymer electrolytes 1 3-Dioxolane Lithium metal-LFP battery
原文传递
上一页 1 2 14 下一页 到第
使用帮助 返回顶部